[Endocrinologic diseases management during breastfeeding]

MeSH terms

• Breast Feeding* / adverse effects
• Bromocriptine / adverse effects
• Bromocriptine / pharmacokinetics
• Bromocriptine / therapeutic use
• Contraindications
• Diabetes Mellitus, Type 2 / prevention & control
• Diet, Diabetic
• Dopamine Agonists / adverse effects
• Dopamine Agonists / pharmacokinetics
• Dopamine Agonists / therapeutic use
• Endocrine System Diseases / drug therapy*
• Endocrine System Diseases / physiopathology
• Estrogens / blood
• Female
• Humans
• Hyperprolactinemia / etiology
• Hyperprolactinemia / physiopathology
• Hypoglycemic Agents / adverse effects
• Hypoglycemic Agents / classification
• Hypoglycemic Agents / pharmacokinetics
• Hypoglycemic Agents / therapeutic use
• Hypopituitarism / drug therapy
• Hypopituitarism / physiopathology
• Infant
• Infant, Newborn
• Insulin / adverse effects
• Insulin / pharmacokinetics
• Insulin / therapeutic use
• Lactation* / physiology
• Milk, Human / chemistry
• Pituitary Neoplasms / complications
• Pituitary Neoplasms / drug therapy
• Pituitary Neoplasms / physiopathology
• Pregnancy
• Pregnancy Complications / drug therapy
• Pregnancy in Diabetics / drug therapy
• Pregnancy in Diabetics / physiopathology
• Prolactin / deficiency
• Prolactinoma / complications
• Prolactinoma / drug therapy
• Prolactinoma / physiopathology
• Puerperal Disorders / drug therapy
• Puerperal Disorders / physiopathology
• Thyroid Diseases / drug therapy
• Thyroid Diseases / physiopathology